Monoclonal Antibody 16D10 to the C-Terminal Domain of the Feto-Acinar Pancreatic Protein Binds to Membrane of Human Pancreatic Tumoral SOJ-6 Cells and Inhibits the Growth of Tumor Xenografts
Autor: | Laurence Panicot-Dubois, Muriel Aubert, Cécile Franceschi, Eric Mas, Françoise Silvy, Christian Crotte, Jean-Paul Bernard, Dominique Lombardo, Marie-Odile Sadoulet |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2004 |
Předmět: | |
Zdroj: | Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 6, Pp 713-724 (2004) |
Druh dokumentu: | article |
ISSN: | 1476-5586 1522-8002 |
DOI: | 10.1593/neo.04298 |
Popis: | Feto-acinar pancreatic protein (FAPP) characterized by mAbJ28 reactivity is a specific component associated with ontogenesis and behaves as an oncodevelopment-associated antigen. We attempted to determine whether pancreatic tumoral SOJ-6 cells are expressed at their surface FAPP antigens and to examine if specific antibodies directed against these FAPP epitopes could decrease the growth of pancreatic tumors in a mice model. For this purpose, we used specific antibodies against either the whole FAPP, the O-glycosylated C-terminal domain, or the N-terminal domain of the protein. Our results indicate that SOJ-6 cells expressed at their surface a 32-kDa peptide corresponding to the C-terminal domain of the FAPP. Furthermore, we show, by using endoproteinase Lys-C or geldanamycin, a drug able to impair the FAPP secretion, that this 32-kDa peptide expressed on the SOJ-6 cell surface comes from the degradation of the FAPP. Finally, an in vivo prospective study using a preventative tumor model in nude mice indicates that targeting this peptide by the use of mAb16D10 inhibits the growth of SOJ-6 xenografts. The specificity of mAb16D10 for pancreatic tumors and the possibility to obtain recombinant structures of mucin-like peptides recognized by mAb16D10 and mAbJ28 are promising tools in immunologic approaches to cure pancreatic cancers. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |